Literature DB >> 17899250

Efficacy and safety of Seprafilm for preventing postoperative abdominal adhesion: systematic review and meta-analysis.

Qiqiang Zeng1, Zhengping Yu, Jie You, Qiyu Zhang.   

Abstract

BACKGROUND: There is no clear consensus on the efficacy and safety of hyaluronate-carboxymethylcellulose membrane (Seprafilm) for preventing postoperative abdominal adhesion. This study is a meta-analysis of the available evidence.
METHODS: A search of the MEDLINE, EMBASE, and the Cochrane Library identified eight studies that met the inclusion criteria for data extraction. Estimates of effectiveness were performed using fixed- and random-effects models. The effect was calculated as an odds ratio (OR) with 95% confidence intervals (CI) using the statistical software Review Manager Version 4.2. Level of significance was set at p < 0.05.
RESULTS: Outcomes of 4203 patients were studied. The incidence of grade 0 adhesions among Seprafilm-treated patients was statistically significantly more than that observed among control group patients (OR 95%CI, 3.74-20.34; p < 0.01). There was no significant difference in the incidence of grade 1 adhesions between Seprafilm and control groups (OR 95%CI, 0.58-2.71; p = 0.56). The severity of grade 2 and grade 3 adhesions among Seprafilm-treated patients was significantly less than that observed among control group patients (OR 95%CI, 0.22-0.93; p = 0.03; OR 95%CI, 0.09-0.63; p < 0.01, respectively). The incidence of intestinal obstruction after abdominal surgery was not different between Seprafilm and control groups (OR 95%CI, 0.78-1.23; p = 0.84). Using Seprafilm significantly increased the incidence of abdominal abscesses (OR 95%CI, 1.06-2.54; p = 0.03) and anastomotic leaks (OR 95%CI, 1.18-3.50; p = 0.01).
CONCLUSIONS: Our systematic review and meta-analysis showed that Seprafilm could decrease abdominal adhesions after general surgery, which may benefit patients, but could not reduce postoperative intestinal obstruction. At the same time, Seprafilm did increase abdominal abscesses and anastomotic leaks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899250     DOI: 10.1007/s00268-007-9242-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  29 in total

1.  The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae.

Authors:  Vassilios S Tsapanos; Lavinia P Stathopoulou; Vassiliki S Papathanassopoulou; Vassilios A Tzingounis
Journal:  J Biomed Mater Res       Date:  2002

Review 2.  Peritoneal adhesions. Incidence, cause, and prevention.

Authors:  D Menzies
Journal:  Surg Annu       Date:  1992

3.  Prevention of postoperative abdominal adhesions by a novel, glycerol/sodium hyaluronate/carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study.

Authors:  Zane Cohen; Anthony J Senagore; Merril T Dayton; Mark J Koruda; David E Beck; Bruce G Wolff; Phillip R Fleshner; Richard C Thirlby; Kirk A Ludwig; Sergio W Larach; Eric G Weiss; Joel J Bauer; Lena Holmdahl
Journal:  Dis Colon Rectum       Date:  2005-06       Impact factor: 4.585

Review 4.  Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management.

Authors:  T Liakakos; N Thomakos; P M Fine; C Dervenis; R L Young
Journal:  Dig Surg       Date:  2001       Impact factor: 2.588

5.  Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial.

Authors:  Masato Kusunoki; Hiroki Ikeuchi; Hidenori Yanagi; Masafumi Noda; Hitoshi Tonouchi; Yasuhiko Mohri; Keiichi Uchida; Yasuhiro Inoue; Minako Kobayashi; Chikao Miki; Takehira Yamamura
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 6.  Preclinical evaluation of Seprafilm bioresorbable membrane.

Authors:  J W Burns; M J Colt; L S Burgees; K C Skinner
Journal:  Eur J Surg Suppl       Date:  1997

7.  Bioresorbable adhesion barrier facilitates early closure of the defunctioning ileostomy after rectal excision: a prospective, randomized trial.

Authors:  Choong-Leong Tang; Francis Seow-Choen; Stephanie Fook-Chong; Kong-Weng Eu
Journal:  Dis Colon Rectum       Date:  2003-09       Impact factor: 4.585

8.  Effects of seprafilm on peritoneal fibrinolytic system.

Authors:  Omer Ridvan Tarhan; Aydan Eroglu; Recep Cetin; Ayper Y Nce; Mahmut Bulbul; Y Rfan Altuntas
Journal:  ANZ J Surg       Date:  2005-08       Impact factor: 1.872

9.  Application of Adcon-P or Seprafilm in consecutive laparotomies using a murine model.

Authors:  Mustafa Oncel; Feza H Remzi; Anthony J Senagore; Jason T Connor; Victor W Fazio
Journal:  Am J Surg       Date:  2004-02       Impact factor: 2.565

10.  Protection of trocar sites from gallbladder cancer implantation by sodium hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm) in a murine model [corrected].

Authors:  T Sasaki; H Shimura; T Tanaka; K Nakashima; K Matsuo; S Ikeda
Journal:  Surg Endosc       Date:  2003-12-29       Impact factor: 4.584

View more
  38 in total

1.  Utilization and safety of sodium hyaluronate-carboxymethylcellulose adhesion barrier.

Authors:  Shazia Bashir; Cande V Ananth; Sharyn N Lewin; William M Burke; Yu-Shiang Lu; Alfred I Neugut; Thomas J Herzog; Dawn L Hershman; Jason D Wright
Journal:  Dis Colon Rectum       Date:  2013-10       Impact factor: 4.585

2.  Efficacy and safety of seprafilm: systematic review and meta-analysis.

Authors:  Yasuhiko Mohri; Masato Kusunoki
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

3.  Seprafilm review and meta-analysis.

Authors:  David E Beck
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

4.  Peritoneal infusion with cold saline decreased postoperative intra-abdominal adhesion formation.

Authors:  Cheng-Chung Fang; Tzung-Hsin Chou; Geng-Shiau Lin; Zui-Shen Yen; Chien-Chang Lee; Shyr-Chyr Chen
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

5.  Development of gelatin flakes, a new type of anti-adhesive material: a preliminary study of in vivo rat adhesion models.

Authors:  Hiroyuki Tsujimoto; Hideki Takamori; Misaki Tsuji; Maho Hayashi; Junki Ikeda; Taichi Orikasa; Hiroko Torii; Yuki Ozamoto; Shuko Suzuki; Shinichiro Morita; Yoshito Ikada; Akeo Hagiwara
Journal:  Surg Today       Date:  2013-05-09       Impact factor: 2.549

Review 6.  Postoperative Abdominal Adhesions: Clinical Significance and Advances in Prevention and Management.

Authors:  Demetrios Moris; Jeffery Chakedis; Amir A Rahnemai-Azar; Ana Wilson; Mairead Marion Hennessy; Antonios Athanasiou; Eliza W Beal; Chrysoula Argyrou; Evangelos Felekouras; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-06       Impact factor: 3.452

7.  Effect of anti-adhesive barrier use on laryngotracheal movement after total thyroidectomy: an electrophysiological study.

Authors:  Zeynep Alkan; Ozgur Yigit; Turgut Adatepe; Nurten Uzun; Ismail Kocak; Volkan Sunter; Ela Araz Server
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-11-05

8.  Effects of amniotic membrane on the healing of primary colonic anastomoses in the cecal ligation and puncture model of secondary peritonitis in rats.

Authors:  Mehmet Uludag; Bulent Citgez; Ozay Ozkaya; Gurkan Yetkin; Omer Ozcan; Nedim Polat; Adnan Isgor
Journal:  Int J Colorectal Dis       Date:  2009-01-27       Impact factor: 2.571

9.  All the commercially available adhesion barriers have the same effect on adhesion prophylaxis?; A comparison of barrier agents using a newly developed, severe intra-abdominal adhesion model.

Authors:  Hyo Jun Hwang; Min Sung An; Tae Kwun Ha; Kwang Hee Kim; Tae Hyeon Kim; Chang Soo Choi; Kwan Hee Hong; Soo Jin Jung; Sun-Hee Kim; Kuk Hwan Rho; Ki Beom Bae
Journal:  Int J Colorectal Dis       Date:  2013-04-16       Impact factor: 2.571

10.  Long-term follow-up of the use of the Jones' intestinal tube in adhesive small bowel obstruction.

Authors:  M Z Fazel; R W Jamieson; C J E Watson
Journal:  Ann R Coll Surg Engl       Date:  2008-11-04       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.